TABLE V.
Chemotherapy | Patients [n (%)] | |
---|---|---|
Receiving | Responding | |
Second-line chemotherapy | 36 | 8 (22) |
Drug | ||
Mitoxantrone | 32 (89) | 6 (19) |
Cytarabine | 2 (5) | 0 |
fac | 1 (3) | 1 |
Carboplatin–etoposide | 1 (3) | 1 |
fac = 5-fluorouacil–doxorubicin–cyclophosphamide.